INNOHEP Side Effects

7026615-2 | Hypersensitivity, Lip Swelling, Swollen Tongue
on Sep 08, 2010 Female patient from UNITED KINGDOM , 36 years of age, weighting 112.4 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, lip swelling, swollen tongue. Innohep dosage: (8900 Iu),subcutaneous.

7023927-3 | Anaemia, Bone Marrow Failure, Haematuria, Thrombocytopenia
Patient was taking Innohep (View Usage). Patient had the following side effects: anaemia, bone marrow failure, haematuria, thrombocytopenia on Oct 28, 2009 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Innohep dosage: 175 Iu/kg (175 Iu/kg,1 In 1 D) , Subcutaneous. Patient was hospitalized.

7023909-1 | Haemoglobin Decreased, Urinary Bladder Haemorrhage
Adverse event was reported on Sep 29, 2009 by a Male patient taking Innohep (View Usage) (Dosage: 175 Units/kg (daily),injection; 175 Units/kg (daily),injection) was diagnosed with pulmonary embolism (What is pulmonary embolism?), thrombosis prophylaxis and. Location: UNITED STATES , 46 years of age, weighting 124.1 lb, After Innohep was administered, patient had the following side effects: haemoglobin decreased, urinary bladder haemorrhage. Patient was hospitalized.

7020550-1 | Deep Vein Thrombosis, Pulmonary Embolism
on Sep 21, 2010 Female patient from FRANCE , 40 years of age, was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Innohep dosage: Subcutaneous.


7018460-9 | Apgar Score Low, Breech Presentation, Congenital Choroid Plexus Cyst, Intraventricular Haemorrhage Neonatal, Premature Baby
on Sep 25, 2010 Male patient from CANADA , weighting 1.23 lb, was diagnosed with antithrombin iii deficiency and was treated with Innohep (View Usage). Patient had the following side effects: apgar score low, breech presentation, congenital choroid plexus cyst, intraventricular haemorrhage neonatal, premature baby. Innohep dosage: 10 000-14 000 Iu (1 In 1 D), Transplacental. During the same period patient was treated with FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

7018422-1 | Anaemia, Gastrointestinal Haemorrhage, Haemangioma, International Normalised Ratio Increased, Oesophagitis, Oxygen Saturation Decreased, Rectal Haemorrhage, Subcutaneous Haematoma
Patient was taking Innohep (View Usage). After Innohep was administered, patient had the following side effects: anaemia, gastrointestinal haemorrhage, haemangioma, international normalised ratio increased, oesophagitis, oxygen saturation decreased, rectal haemorrhage, subcutaneous haematoma on Sep 13, 2010 from AFGHANISTAN Additional patient health information: Female patient , 87 years of age, was diagnosed with phlebitis and. Innohep dosage: 14000 Iu (1 In 1 D),subcutaneous. During the same period patient was treated with PREVISCAN (FLUINDIONE) (20 MILLIGRAM, TABLETS) (20 Mg (1 In 1 D),oral) (View Previscan (fluindione) (20 Milligram, Tablets) Review and Previscan (fluindione) (20 Milligram, Tablets) Label ), CORDARONE (View Cordarone Review and Cordarone Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (75 MILLIGRAM) (View Kardegic (acetylsalicylate Lysine) (75 Milligram) Review and Kardegic (acetylsalicylate Lysine) (75 Milligram) Label ), EUPHYLLINE (AMINOPHYLLINE) (View Euphylline (aminophylline) Review and Euphylline (aminophylline) Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEXOMIL (BROMAZEPAM) (View Lexomil (bromazepam) Review and Lexomil (bromazepam) Label ). Patient was hospitalized.

7014590-6 | Areflexia, Dysarthria, Haemoglobin Decreased, Hydrocephalus, Intracranial Tumour Haemorrhage, Unresponsive To Stimuli
Adverse event was reported on Sep 14, 2010 by a Male patient taking Innohep (View Usage) (Dosage: ) . Location: UNITED STATES , 69 years of age, Patient experienced the following unwanted or unexpected effects: areflexia, dysarthria, haemoglobin decreased, hydrocephalus (What is hydrocephalus?), intracranial tumour haemorrhage, unresponsive to stimuli.

7006054-0 | Needle Issue, Premature Labour
on Sep 07, 2010 Female patient from IRELAND , 39 years of age, weighting 172.6 lb, was treated with Innohep (View Usage). Patient had the following side effects: needle issue, premature labour. Innohep dosage: 19000 Iu (19000 Iu,1 In D),subcutaneous.

7003493-9 | Lip Swelling, Swollen Tongue
on Sep 08, 2010 Female patient from UNITED KINGDOM , weighting 112.4 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: lip swelling, swollen tongue. Innohep dosage: (8900 Iu), Subcutantous.

6992604-7 | Cellulitis, Erythema, Overdose, Pruritus, Rash Macular, Skin Exfoliation, Toxic Skin Eruption
Patient was taking Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), erythema, overdose, pruritus, rash macular, skin exfoliation, toxic skin eruption on Sep 03, 2010 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Innohep dosage: 18000 Iu (18000 Iu, 1 In 1 D), Subcutaneous. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (3 G (1 Gm, 3 In 1 In D) Oral; 4 Gm (1 Gm,4 In 1 D),oral) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), CLAMOXYL (AMOXICILLIN) (1 GRAM) (3 Gm (1 Gm, 3 In 1 D), Oral; 4 Gm (1 Gm,4 In 1 D),oral) (View Clamoxyl (amoxicillin) (1 Gram) Review and Clamoxyl (amoxicillin) (1 Gram) Label ), PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), ARIXTRA (View Arixtra Review and Arixtra Label ). Patient was hospitalized.

6985147-8 | Heparin-induced Thrombocytopenia, Leukaemia
Adverse event was reported on Sep 01, 2010 by a Male patient taking Innohep (View Usage) (Dosage: (175 Iu/kg), Subcutaneous) . Location: IRELAND , 75 years of age, Patient had the following side effects: heparin-induced thrombocytopenia, leukaemia. Patient was hospitalized.

6980741-2 | Pregnancy, Skin Ulcer
on Jul 20, 2009 Female patient from UNITED STATES , 38 years of age, weighting 249.8 lb, was diagnosed with thrombosis prophylaxis and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: pregnancy (What is pregnancy?), skin ulcer. Innohep dosage: 4500 Iu (1 In 1 D). During the same period patient was treated with SYTOMETRINE (OXYTOCIN, ERGOMETRINE) (View Sytometrine (oxytocin, Ergometrine) Review and Sytometrine (oxytocin, Ergometrine) Label ), SYNTOCINON (View Syntocinon Review and Syntocinon Label ).

6980111-7 | Embolism Arterial, Thrombosis
on Aug 26, 2010 Male patient from CANADA , 61 years of age, was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: embolism arterial, thrombosis. Innohep dosage: (1800 Iu).

6971035-X | Disease Recurrence, Embolism Arterial, Thrombosis
Patient was taking Innohep (View Usage). Patient had the following side effects: disease recurrence, embolism arterial, thrombosis on Aug 26, 2010 from CANADA Additional patient health information: Male patient , 61 years of age, . Innohep dosage: (18000 Iu).

6963033-7 | Blood Pressure Decreased, Gastrointestinal Haemorrhage, Tachycardia
Adverse event was reported on Aug 18, 2010 by a Female patient taking Innohep (View Usage) (Dosage: ) was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Location: SWEDEN , 83 years of age, After Innohep was administered, patient had the following side effects: blood pressure decreased, gastrointestinal haemorrhage, tachycardia. During the same period patient was treated with ENALAPRIL (ENALAPRIL) (TABLETS) (View Enalapril (enalapril) (tablets) Review and Enalapril (enalapril) (tablets) Label ), IMPUGAN (FUROSEMIDE) (TABLETS) (View Impugan (furosemide) (tablets) Review and Impugan (furosemide) (tablets) Label ). Patient was hospitalized.

6955970-4 | Blood Creatinine Increased, Duodenal Ulcer, Faeces Discoloured, Gastritis, Haematemesis, Haemoglobin Decreased, Headache, Hypoprothrombinaemia, Scar
on Aug 13, 2010 Male patient from FRANCE , 17 years of age, was diagnosed with vena cava thrombosis and was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, duodenal ulcer, faeces discoloured, gastritis, haematemesis, haemoglobin decreased, headache (What is headache?), hypoprothrombinaemia, scar (What is scar?). Innohep dosage: Subcutaneous. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), GAMMAGARD (View Gammagard Review and Gammagard Label ). Patient was hospitalized.

6940622-7 | Haemoglobin Decreased, Hydrocephalus, Tumour Haemorrhage
on Aug 04, 2010 Male patient from UNITED STATES , 69 years of age, was treated with Innohep (View Usage). Patient had the following side effects: haemoglobin decreased, hydrocephalus (What is hydrocephalus?), tumour haemorrhage. Innohep dosage: .

6928456-0 | Anaemia, Blood Creatinine Increased, Blood Pressure Diastolic Decreased, Conjunctival Pallor, International Normalised Ratio Increased, Intestinal Haemorrhage, Peritoneal Haematoma, Syncope
Patient was taking Innohep (View Usage). After Innohep was administered, patient had the following side effects: anaemia, blood creatinine increased, blood pressure diastolic decreased, conjunctival pallor, international normalised ratio increased, intestinal haemorrhage, peritoneal haematoma, syncope on Jul 30, 2010 from FRANCE Additional patient health information: Male patient , 74 years of age, . Innohep dosage: 24000 Iu (12000 Iu, 2 In 1 D, Subcutaneous. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), URBANYL (CLOBAZAM) (View Urbanyl (clobazam) Review and Urbanyl (clobazam) Label ), PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ). Patient was hospitalized.

6925887-X | Acute Lung Injury, Acute Pulmonary Oedema, Cardiomegaly, Foreign Travel, Haemodialysis-induced Symptom, Kidney Transplant Rejection, Malaria Prophylaxis, Nephrectomy, Visual Impairment
Adverse event was reported on Jul 27, 2010 by a Female patient taking Innohep (View Usage) (Dosage: (since 2008), Hemodialysis) was diagnosed with dialysis (What is dialysis?) and. Location: UNITED KINGDOM , 63 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: acute lung injury, acute pulmonary oedema, cardiomegaly, foreign travel, haemodialysis-induced symptom, kidney transplant rejection, malaria prophylaxis, nephrectomy, visual impairment. Patient was hospitalized.

6917221-6 | Cardiac Valve Replacement Complication, Cardiogenic Shock
on Jul 21, 2010 Female patient from SPAIN , 39 years of age, was treated with Innohep (View Usage). Patient had the following side effects: cardiac valve replacement complication, cardiogenic shock. Innohep dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6917167-3 | Haematoma, Joint Injury, Off Label Use
on Jul 23, 2010 Female patient from FRANCE , 72 years of age, was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: haematoma, joint injury, off label use. Innohep dosage: (18000 Iu), Subcutaneous. During the same period patient was treated with PREVISCAN (FLUINDIONE) (20 MILLIGRAM, TABLETS) (Oral) (View Previscan (fluindione) (20 Milligram, Tablets) Review and Previscan (fluindione) (20 Milligram, Tablets) Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (160 MILLIGRAM) (Oral) (View Kardegic (acetylsalicylate Lysine) (160 Milligram) Review and Kardegic (acetylsalicylate Lysine) (160 Milligram) Label ), ZOCOR (SIMVASTATIN) (40 MILLIGRAM, TABLETS) (View Zocor (simvastatin) (40 Milligram, Tablets) Review and Zocor (simvastatin) (40 Milligram, Tablets) Label ), EUPRESSYL (URAPIDIL)(60 MILLIGRAM, CAPSULES) (View Eupressyl (urapidil)(60 Milligram, Capsules) Review and Eupressyl (urapidil)(60 Milligram, Capsules) Label ), TENORMINE (ATENOLOL) (100 MILLIGRAM, TABLETS) (View Tenormine (atenolol) (100 Milligram, Tablets) Review and Tenormine (atenolol) (100 Milligram, Tablets) Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ALDACTONE (SPIRONOLACTONE) (25 MILLIGRAM, TABLETS) (View Aldactone (spironolactone) (25 Milligram, Tablets) Review and Aldactone (spironolactone) (25 Milligram, Tablets) Label ). Patient was hospitalized.

6906041-4 | Dyspnoea, Epistaxis, Haemoglobin Decreased, Post Procedural Haemorrhage
Patient was taking Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, epistaxis, haemoglobin decreased, post procedural haemorrhage on Jul 22, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with phlebitis and. Innohep dosage: 14000 Iu (14000 Iu, 1 In 1 D, Subcutaneous. During the same period patient was treated with LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ). Patient was hospitalized.

6894798-0 | Heparin-induced Thrombocytopenia, Pulmonary Embolism, Thrombosis
Adverse event was reported on Jul 15, 2010 by a Male patient taking Innohep (View Usage) (Dosage: 1800 Iu (1800 Iu,1 In 1 D),subcutaneous) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: FRANCE , 62 years of age, Patient had the following side effects: heparin-induced thrombocytopenia, pulmonary embolism (What is pulmonary embolism?), thrombosis. During the same period patient was treated with ENOXAPARIN SODIUM (4000 Iu (4000 Iu,1 In 1 D),subcutaneous) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), NADROPARIN (NADROPARIN) (INJECTION) (8000 Iu (8000 Iu,1 In 1 D),subcutaneous) (View Nadroparin (nadroparin) (injection) Review and Nadroparin (nadroparin) (injection) Label ), ACTISKENAN (MORPHINE SULFATE) (10 MILLIGRAM, CAPSULES) (View Actiskenan (morphine Sulfate) (10 Milligram, Capsules) Review and Actiskenan (morphine Sulfate) (10 Milligram, Capsules) Label ), DOLIPRANE (PARACETAMOL) (1 GRAM, TABLETS) (View Doliprane (paracetamol) (1 Gram, Tablets) Review and Doliprane (paracetamol) (1 Gram, Tablets) Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), PROFENID (KETOPROFEN) (50 MILLIGRAM, CAPSULES) (View Profenid (ketoprofen) (50 Milligram, Capsules) Review and Profenid (ketoprofen) (50 Milligram, Capsules) Label ), NORMACOL (STERCULIA URENS, RHAMNUS FRANGULA EXTRACT) (View Normacol (sterculia Urens, Rhamnus Frangula Extract) Review and Normacol (sterculia Urens, Rhamnus Frangula Extract) Label ), INEXIUM (ESOMEPRAZOLE MAGNESIUM) (20 MILLIGRAM, TABLETS) (View Inexium (esomeprazole Magnesium) (20 Milligram, Tablets) Review and Inexium (esomeprazole Magnesium) (20 Milligram, Tablets) Label ). Patient was hospitalized.

6894281-2 | Haemorrhage, Premature Baby
on Jul 16, 2010 Male patient from CANADA , weighting 1.23 lb, was diagnosed with antithrombin iii deficiency and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: haemorrhage, premature baby. Innohep dosage: 10 000-14 000 Iu 1 In 1 D, Transplacental. During the same period patient was treated with FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6883299-1 | Fibula Fracture, Foetal Hypokinesia, Nausea, Pulmonary Embolism, Urinary Tract Infection, Uterine Pain
on May 21, 2010 Female patient from IRELAND , 30 years of age, weighting 152.1 lb, was diagnosed with thrombosis prophylaxis and was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: fibula fracture, foetal hypokinesia, nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?), urinary tract infection (What is urinary tract infection?), uterine pain. Innohep dosage: See Image. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ), PHENERGAN (PROMETHAZINE) (View Phenergan (promethazine) Review and Phenergan (promethazine) Label ), CEPHRADINE (View Cephradine Review and Cephradine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6883247-4 | Premature Separation Of Placenta
Patient was taking Innohep (View Usage). Patient had the following side effects: premature separation of placenta on May 05, 2010 from DENMARK Additional patient health information: Female patient , 26 years of age, weighting 125.7 lb, was diagnosed with thrombosis prophylaxis and. Innohep dosage: (4500 Iu). During the same period patient was treated with PENICILLIN (BENZYL PENICILLIN) (View Penicillin (benzyl-penicillin) Review and Penicillin (benzyl-penicillin) Label ), VITAMINS (VITAMINS /90003601/) (View Vitamins (vitamins /90003601/) Review and Vitamins (vitamins /90003601/) Label ). Patient was hospitalized.

6862736-2 | Cerebrovascular Accident, Disease Recurrence, Off Label Use, Subdural Haematoma
Adverse event was reported on Jul 08, 2010 by a Male patient taking Innohep (View Usage) (Dosage: 1 In 1 D, Subcutaneous) was diagnosed with cerebrovascular accident and. Location: FRANCE , 81 years of age, After Innohep was administered, patient had the following side effects: cerebrovascular accident, disease recurrence, off label use, subdural haematoma. During the same period patient was treated with PLAVIX (Oral) (View Plavix Review and Plavix Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (75 MILLIGRAM) (Oral) (View Kardegic (acetylsalicylate Lysine) (75 Milligram) Review and Kardegic (acetylsalicylate Lysine) (75 Milligram) Label ).

6862733-7 | Alanine Aminotransferase Abnormal, Aspartate Aminotransferase Abnormal, Blood Creatine Phosphokinase Abnormal, Depression, Device Related Infection, Gamma-glutamyltransferase Abnormal, Haematocrit Abnormal, Haemoglobin Decreased, Peripheral Nerve Lesion
on Jul 02, 2010 Female patient from GREECE , 56 years of age, weighting 143.3 lb, was diagnosed with thrombosis prophylaxis and was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood creatine phosphokinase abnormal, depression (What is depression?), device related infection, gamma-glutamyltransferase abnormal, haematocrit abnormal, haemoglobin decreased, peripheral nerve lesion. Innohep dosage: 4500 Iu (1 In 1 D), Subcutaneous. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ), ONDA (ONDANSETRON HYDROCHLORIDE) (View Onda (ondansetron Hydrochloride) Review and Onda (ondansetron Hydrochloride) Label ), LONALGAL (CODEINE PHOSPHATE, PARACETAMOL) (View Lonalgal (codeine Phosphate, Paracetamol) Review and Lonalgal (codeine Phosphate, Paracetamol) Label ), ZINACEF (View Zinacef Review and Zinacef Label ). Patient was hospitalized and became disabled.

6856929-8 | Abdominal Pain, Diarrhoea, Nausea, Off Label Use, Presyncope
on Jun 30, 2010 Female patient from FRANCE , 76 years of age, weighting 134.5 lb, was diagnosed with vitamin k and was treated with Innohep (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, nausea (What is nausea?), off label use, presyncope. Innohep dosage: 10000 Iu (10000 Iu, 1 In 1 D), Subuctaneous. During the same period patient was treated with PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ). Patient was hospitalized.

6856808-6 | Caesarean Section, Cryptorchism, Premature Baby
Patient was taking Innohep (View Usage). After Innohep was administered, patient had the following side effects: caesarean section, cryptorchism, premature baby on May 31, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 6.61 lb, . Innohep dosage: Transplacental. During the same period patient was treated with FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), CO DYDRAMOL (PARACETAMOL, DIHYDROCODEINE BITARTRATE) (View Co-dydramol (paracetamol, Dihydrocodeine Bitartrate) Review and Co-dydramol (paracetamol, Dihydrocodeine Bitartrate) Label ), GAVISCON (SODIUM BICARBONATE, ALUMINUM HYDROXIDE GEL, DRIED, ALGINIC A (View Gaviscon (sodium Bicarbonate, Aluminum Hydroxide Gel, Dried, Alginic A Review and Gaviscon (sodium Bicarbonate, Aluminum Hydroxide Gel, Dried, Alginic A Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6848061-4 | Acute Lung Injury, Acute Pulmonary Oedema, C-reactive Protein Increased, Cardiomegaly
Adverse event was reported on Jun 04, 2010 by a Female patient taking Innohep (View Usage) (Dosage: Hemodialysis) was diagnosed with dialysis (What is dialysis?) and. Location: UNITED KINGDOM , 63 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: acute lung injury, acute pulmonary oedema, c-reactive protein increased, cardiomegaly. Patient was hospitalized.

6848060-2 | Thrombophlebitis
on Jul 05, 2010 Female patient from FRANCE , 54 years of age, was treated with Innohep (View Usage). Patient had the following side effects: thrombophlebitis. Innohep dosage: 4500 Iu (4500 Iu, 1 In 1 D), Subcutaneous. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CHONDROSULF (CHONDROITIN SULFATE SODIUM) (View Chondrosulf (chondroitin Sulfate Sodium) Review and Chondrosulf (chondroitin Sulfate Sodium) Label ), COZAAR (View Cozaar Review and Cozaar Label ), LOVENOX (View Lovenox Review and Lovenox Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), NEXIUM (View Nexium Review and Nexium Label ).

6843558-5 | Anaemia, Bedridden, Deep Vein Thrombosis, Off Label Use
on Jun 15, 2010 Male patient from FRANCE , 98 years of age, weighting 130.1 lb, was diagnosed with thrombosis prophylaxis and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: anaemia, bedridden, deep vein thrombosis (What is deep vein thrombosis?), off label use. Innohep dosage: 4500 Iu (4500 Iu, 1 D), Subcutaneous. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), VASTAREL (TRIMETAZIDINE HYDROCHLORIDE) (View Vastarel (trimetazidine Hydrochloride) Review and Vastarel (trimetazidine Hydrochloride) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6843548-2 | Off Label Use, Overdose, Spontaneous Haematoma
Patient was taking Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, overdose, spontaneous haematoma on Jun 29, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, weighting 103.6 lb, was diagnosed with angina unstable and. Innohep dosage: 10000 Iu (10000 Iu, 1 In 1 D), Subcutaneous. During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), EQUANIL (View Equanil Review and Equanil Label ). Patient was hospitalized.

6843008-9 | Compartment Syndrome, Haematoma, Skin Graft
Adverse event was reported on Jun 23, 2010 by a Female patient taking Innohep (View Usage) (Dosage: (14000 Iu), Subcutaneous) was diagnosed with phlebitis and. Location: BELGIUM , 86 years of age, weighting 149.9 lb, Patient had the following side effects: compartment syndrome, haematoma, skin graft. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ENBREL (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

6829028-9 | Accidental Overdose
on Jun 21, 2010 Female patient from FRANCE , weighting 22.05 lb, was diagnosed with jugular vein thrombosis and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: accidental overdose. Innohep dosage: 2500 Iu (2500 Iu, Once, Subcutaneous) 12000 Iu 1 In 1 D, Subcutaneous, 250 Iu 1 In 1 D, Subcutaneous. Patient was hospitalized.

6812390-0 | Cholestasis Of Pregnancy, Postpartum Haemorrhage, Venous Insufficiency
on Jan 30, 2008 Female patient from SPAIN , 30 years of age, weighting 108.0 lb, was diagnosed with thrombosis prophylaxis and was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis of pregnancy, postpartum haemorrhage, venous insufficiency. Innohep dosage: 10000 Iu (10000 Iu, 1 In 1 D). During the same period patient was treated with DAFLON (DIOSMIN) (View Daflon (diosmin) Review and Daflon (diosmin) Label ), URSOCHOL (URSODEOXYCHOLIC ACID) (View Ursochol (ursodeoxycholic Acid) Review and Ursochol (ursodeoxycholic Acid) Label ), POLARAMINE (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

6800763-1 | Abdominal Discomfort, Caesarean Section, Fall, Premature Labour
Patient was taking Innohep (View Usage). Patient had the following side effects: abdominal discomfort, caesarean section, fall (What is fall?), premature labour on Jun 11, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 19 years of age, weighting 216.1 lb, was diagnosed with embolism venous and. Innohep dosage: 16000 Iu (16000 Iu, 1 In 1 D), Subcutaneous. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ). Patient was hospitalized.

6800758-8 | Caesarean Section, Premature Baby
Adverse event was reported on Jun 23, 2008 by a Female patient taking Innohep (View Usage) (Dosage: Transplacental) . Location: UNITED KINGDOM , weighting 4.54 lb, After Innohep was administered, patient had the following side effects: caesarean section, premature baby. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ). Patient was hospitalized.

6800757-6 | Caesarean Section, Premature Baby
on Dec 17, 2007 Female patient from UNITED KINGDOM , weighting 6.94 lb, was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, premature baby. Innohep dosage: Transplacental. During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), INSULIN GLARGINE (INSULIN GLARGINE) (View Insulin Glargine (insulin Glargine) Review and Insulin Glargine (insulin Glargine) Label ), INSULIN NOVORAPID (INSULIN ASPART) (View Insulin Novorapid (insulin Aspart) Review and Insulin Novorapid (insulin Aspart) Label ). Patient was hospitalized.

6796381-4 | Multiple Pregnancy, Premature Baby, Stillbirth
on Dec 09, 2008 Male patient from DENMARK , weighting 0.88 lb, was treated with Innohep (View Usage). Patient had the following side effects: multiple pregnancy, premature baby, stillbirth. Innohep dosage: Transplacental. During the same period patient was treated with CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), MAGNESIA (MAGNESIUM HYDROXIDE) (View Magnesia (magnesium Hydroxide) Review and Magnesia (magnesium Hydroxide) Label ).

6796380-2 | Caesarean Section, Neonatal Respiratory Distress Syndrome, Patent Ductus Arteriosus, Premature Baby
Patient was taking Innohep (View Usage). After Innohep was administered, patient had the following side effects: caesarean section, neonatal respiratory distress syndrome, patent ductus arteriosus, premature baby on Sep 09, 2008 from DENMARK Additional patient health information: Female patient , weighting 1.63 lb, . Innohep dosage: Transplacental. During the same period patient was treated with PHENEMAL (PHENOBARBITAL) (View Phenemal (phenobarbital) Review and Phenemal (phenobarbital) Label ), NEPRESOL (DIHYDRALAZINE SULFATE) (View Nepresol (dihydralazine Sulfate) Review and Nepresol (dihydralazine Sulfate) Label ), TRANDATE (View Trandate Review and Trandate Label ). Patient was hospitalized.

6796378-4 | Asthma, Vomiting In Pregnancy
Adverse event was reported on Jan 17, 2008 by a Female patient taking Innohep (View Usage) (Dosage: 4500 Iu (4500 Iu, 1 In 1 D), 4500 Iu (4500 Iu, 1 In 1 D)) was diagnosed with thrombosis prophylaxis and. Location: IRELAND , 28 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), vomiting in pregnancy. During the same period patient was treated with SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ). Patient was hospitalized.

6796377-2 | Premature Baby
on Dec 09, 2008 Female patient from DENMARK , weighting 1.14 lb, was treated with Innohep (View Usage). Patient had the following side effects: premature baby. Innohep dosage: Transplacental. During the same period patient was treated with CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), CONFORTID (INDOMETACIN) (View Confortid (indometacin) Review and Confortid (indometacin) Label ). Patient was hospitalized.

6796376-0 | Labour Pain, Premature Labour, Thrombophlebitis, Tonsillitis, Urinary Tract Infection
on Jun 11, 2010 Female patient from IRELAND , 23 years of age, weighting 156.5 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: labour pain, premature labour, thrombophlebitis, tonsillitis, urinary tract infection (What is urinary tract infection?). Innohep dosage: 12000 Iu (12000 Iu, 1 In 1 D), Subcutaneous. Patient was hospitalized.

6796360-7 | Heparin-induced Thrombocytopenia
Patient was taking Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia on May 13, 2010 from Additional patient health information: Male patient , 75 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Innohep dosage: (175 Iu/kg), Subcutaneous.

6795554-4 | Immature Respiratory System, Premature Baby
Adverse event was reported on Sep 29, 2008 by a Male patient taking Innohep (View Usage) (Dosage: Transplacental) . Location: DENMARK , weighting 2.49 lb, Patient had the following side effects: immature respiratory system, premature baby. During the same period patient was treated with PONDOCILLIN (PIVAMPICILLIN HYDROCHLORIDE) (View Pondocillin (pivampicillin Hydrochloride) Review and Pondocillin (pivampicillin Hydrochloride) Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6795553-2 | Atrial Fibrillation, Brain Oedema, Cerebrovascular Accident, Dermatitis, Disturbance In Attention, Extradural Haematoma, Glycosylated Haemoglobin Increased, Heart Sounds Abnormal, Hepatomegaly
on Jun 10, 2010 Female patient from FRANCE , 65 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Innohep (View Usage). After Innohep was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), brain oedema, cerebrovascular accident, dermatitis, disturbance in attention, extradural haematoma, glycosylated haemoglobin increased, heart sounds abnormal, hepatomegaly. Innohep dosage: 14000 Iu, Subcutaneous. During the same period patient was treated with PREVISCAN (FLUINDIONE) (20 MILLIGRAM, TABLETS) (Oral) (View Previscan (fluindione) (20 Milligram, Tablets) Review and Previscan (fluindione) (20 Milligram, Tablets) Label ), AMLOR (AMLODIINE BESILATE) (View Amlor (amlodiine Besilate) Review and Amlor (amlodiine Besilate) Label ), PRETERAX (INDAPAMIDE, PERINDOPRIL ERBUMINE) (View Preterax (indapamide, Perindopril Erbumine) Review and Preterax (indapamide, Perindopril Erbumine) Label ), HEMIGOXIN (DIGOXIN) (View Hemigoxin (digoxin) Review and Hemigoxin (digoxin) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6795535-0 | Congenital Anomaly, Congenital Choroid Plexus Cyst, Premature Baby
on Jun 09, 2010 Female patient from UNITED KINGDOM , weighting 5.56 lb, was treated with Innohep (View Usage). Patient experienced the following unwanted or unexpected effects: congenital anomaly, congenital choroid plexus cyst, premature baby. Innohep dosage: Transplacental. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PENICILLIN V (View Penicillin V Review and Penicillin V Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ), PROZAC (View Prozac Review and Prozac Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6795533-7 | Premature Baby
Patient was taking Innohep (View Usage). Patient had the following side effects: premature baby on Jun 23, 2008 from Additional patient health information: Male patient , weighting 5.51 lb, . Innohep dosage: Transplacental. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PENECILLIN V (PHENOXYMETHYLPENICILLIN) (View Penecillin V (phenoxymethylpenicillin) Review and Penecillin V (phenoxymethylpenicillin) Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.